Breaking News
Get 55% Off 0
🔺 What to do when markets are at an all-time high? Find smart bargains, like these.
See Undervalued Stocks
Close

AstraZeneca PLC (AZNs)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1,489.50 0.00    0.00%
09/12 - Delayed Data. Currency in SEK
Type:  Equity
Market:  Euro Zone
ISIN:  GB0009895292 
  • Volume: 0
  • Bid/Ask: 1,493.50 / 1,472.00
  • Day's Range: 1,489.50 - 1,495.50
AstraZeneca 1,489.50 0.00 0.00%

AZNs Financial Summary

 
A brief financial summary of AstraZeneca PLC as well as the most significant critical numbers from each of its financial reports. In addition, some financial ratios derived from these reports are featured. Users can opt to see 4 periods of either annual or quarterly information.

AstraZeneca PLC reported earnings results for the third quarter and nine months ended September 30, 2024. For the third quarter, the company reported sales was USD 559 million compared to USD 377 million a year ago. Revenue was USD 13,565 million compared to USD 11,492 million a year ago. Net income was USD 1,429 million compared to USD 1,374 million a year ago. Basic earnings per share from continuing operations was USD 0.92 compared to USD 0.89 a year ago. Diluted earnings per share from continuing operations was USD 0.91 compared to USD 0.88 a year ago. For the nine months, sales was USD 1,498 million compared to USD 1,004 million a year ago. Revenue was USD 39,182 million compared to USD 33,787 million a year ago. Net income was USD 5,535 million compared to USD 4,995 million a year ago. Basic earnings per share from continuing operations was USD 3.57 compared to USD 3.22 a year ago. Diluted earnings per share from continuing operations was USD 3.54 compared to USD 3.2 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

AZNs Income Statement

Gross margin TTM 82.61%
Operating margin TTM 26.7%
Net Profit margin TTM 12.68%
Return on Investment TTM 16.11%
 Total Revenue  Net Income
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Revenue 13565 12938 12679 12024
Gross Profit 11103 10771 10481 9729
Operating Income 3315 2900 3310 2034
Net Income 1429 1927 2179 960

AZNs Balance Sheet

Quick Ratio MRQ 0.65
Current Ratio MRQ 0.93
LT Debt to Equity MRQ 71.03%
Total Debt to Equity MRQ 77.64%
 Total Assets  Total Liabilities
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Total Assets 104922 104340 102293 101119
Total Liabilities 64117 64742 64792 61953
Total Equity 40805 39598 37501 39166

AZNs Cash Flow Statement

Cash Flow/Share TTM 7.31
Revenue/Share TTM 33.03
Operating Cash Flow  13.05%
 Cash  Net Change in Cash
Period Ending: Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 3383 3085 2486 2380
Cash From Investing Activities -1514 -2872 -2413 -1077
Cash From Financing Activities -4131 -1222 2028 -291
Net Change in Cash -2242 -1015 2055 1018
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

AZN Comments

Write your thoughts about AstraZeneca PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Thamsanqa Khulela
Thamsanqa Khulela Jan 23, 2021 2:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
which broker can I get Astrazeneca on?
Sandile Ntombela
Sandile Ntombela Jan 23, 2021 2:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
trading 212
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email